Prelude Capital Management’s PepperLime Health Acquisition Corporation Unit PEPLU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-155,541
Closed -$1.58M 2553
2021
Q4
$1.58M Buy
+155,541
New +$1.55M 0.04% 392

Other funds holding PEPLU

Prelude Capital Management's PEPLU Position: Q1 2022 in Review

Prelude Capital Management sold out of PepperLime Health Acquisition Corporation Unit (PEPLU) in Q1 2022, closing a stake of 155,541 shares — an estimated $1.58M sold.

Prelude Capital Management first reported a position in PEPLU in Q4 2021 and held it in 1 quarter. The position peaked at $1.58M in Q4 2021. 15 funds tracked by Wall St. Rank hold PEPLU as of Q1 2022.

  • Prelude Capital Management reported no remaining PepperLime Health Acquisition Corporation Unit position as of Q1 2022 after selling out during the quarter.
  • Prelude Capital Management sold 155,541 PepperLime Health Acquisition Corporation Unit shares in Q1 2022, an estimated $1.58M.
  • Prelude Capital Management first reported a position in PepperLime Health Acquisition Corporation Unit in Q4 2021 and held it in 1 quarter.
  • Prelude Capital Management's PepperLime Health Acquisition Corporation Unit position peaked at $1.58M in Q4 2021.
  • 15 funds tracked by Wall St. Rank held PepperLime Health Acquisition Corporation Unit as of Q1 2022.

Based on Prelude Capital Management's 13F filing for Q1 2022, filed 16 May 2022.